How to Treat Vaginal Dryness in Sjögren's Syndrome
Published: | Updated:
Vaginal dryness in Sjögren's syndrome is best managed by combining regular vaginal moisturizers for daily tissue health and lubricants to reduce friction during sex. If over-the-counter options fail, localized vaginal estrogen is a safe and highly effective prescription treatment.
Key Takeaways
- • Vaginal moisturizers should be used regularly to hydrate tissues, while lubricants are strictly for on-demand use during sexual activity.
- • When choosing over-the-counter products, avoid irritants like glycerin, parabens, or artificial fragrances.
- • Localized vaginal estrogen in the form of low-dose creams, tablets, or rings is a highly effective and safe treatment for severe dryness.
- • Vaginal DHEA (Prasterone) offers an effective prescription alternative for patients who cannot use estrogen.
Vaginal dryness and painful sex are incredibly common but rarely discussed symptoms of Sjögren’s syndrome. Because Sjögren’s attacks the body’s moisture-producing glands, it affects the vaginal tissues just as it affects the eyes and mouth [1][2]. The best approach to managing severe vaginal dryness combines two non-hormonal strategies: using vaginal moisturizers regularly for daily tissue health, and using lubricants on-demand to reduce friction during intimacy [3][4]. If these over-the-counter options do not provide enough relief, localized prescription treatments like vaginal estrogen are highly effective and safe next steps [5][6].
Understanding Moisturizers vs. Lubricants
Many patients use lubricants hoping they will cure daily dryness, or use moisturizers right before sex, but these products serve completely different purposes.
Vaginal moisturizers are designed for regular, frequent use (usually every few days) to provide long-lasting hydration and improve overall tissue health [3][7]. They are absorbed by the skin and work to relieve chronic dryness, itching, and irritation even when you are not having sex [8]. They can be applied externally to the vulva or inserted internally using an applicator. Many high-quality moisturizers use hyaluronic acid [3], a substance naturally found in the body that holds onto water and helps keep tissues plump and hydrated.
Vaginal lubricants, on the other hand, are intended strictly for on-demand use right before and during sexual activity [3][9]. They sit on the surface of the skin to temporarily reduce friction and prevent dyspareunia (the medical term for painful sex) [4]. Note: If you use latex condoms for contraception or STI prevention, always choose a water-based or silicone-based lubricant, as oil-based products will destroy the latex.
When choosing these products, it is important to read the labels. Some over-the-counter options contain additives or have a pH (acidity level) that does not match natural vaginal tissues (which should be between 3.8 and 4.5), which can cause burning or further irritation [10]. Look for products specifically formulated for sensitive skin. It is best to avoid known irritants like glycerin, parabens, artificial fragrances, colors, or warming/cooling chemicals.
When to Ask About Prescription Options
While daily moisturizers and on-demand lubricants are the foundation of non-hormonal management, they are not always enough for severe Sjögren’s symptoms [11]. If you have been using a moisturizer consistently for about 4 weeks but are still experiencing daily discomfort or painful sex, it is time to talk to your gynecologist [12][6].
The most common and effective medical step-up is localized vaginal estrogen [5][13]. Unlike oral estrogen pills that affect the whole body, localized estrogen comes in low-dose creams, tablets, or rings inserted directly into the vagina. It works directly on the tissues to restore thickness, elasticity, and natural moisture [14].
Research shows that the amount of estrogen absorbed into the bloodstream from these local treatments is biologically insignificant, making them very safe for the vast majority of women [15][16]. Keep in mind that the FDA mandates a standardized “black box” warning insert for all estrogen products based on the risks of high-dose, whole-body pills. Do not let this insert panic you—discuss any safety concerns directly with your doctor. (For those who cannot use any form of estrogen, other localized options like vaginal DHEA/Prasterone are also available [17]).
Vaginal dryness heavily impacts your quality of life, and you do not have to just “live with it” [11]. Gynecologists treat this exact issue every single day, so there is no need to feel embarrassed about bringing it up.
Frequently Asked Questions
What is the difference between vaginal moisturizers and lubricants?
Are over-the-counter vaginal products safe to use with Sjögren's syndrome?
What should I do if moisturizers and lubricants don't relieve my vaginal dryness?
Is prescription localized vaginal estrogen safe to use?
What if I cannot use estrogen for my vaginal dryness?
Questions for Your Doctor
- • I have been using non-hormonal moisturizers regularly for several weeks but still have severe dryness. Am I a good candidate for low-dose localized vaginal estrogen?
- • Based on my symptoms, would an estrogen cream, tablet, or ring be the most practical option for me?
- • What specific brand or type of vaginal moisturizer do you recommend for patients with sensitive tissues from Sjögren's?
- • How can we distinguish between dryness caused by Sjögren's and other potential issues like a low-grade infection or pelvic floor dysfunction?
- • If estrogen is not right for me, are there other prescription alternatives, like vaginal DHEA (Prasterone), that might help?
Questions for You
- • How frequently am I currently using moisturizers versus lubricants, and am I using them for their intended purposes?
- • Are my symptoms limited to pain during sex, or do I also feel burning, itching, or discomfort while walking or sitting?
- • Have the over-the-counter products I've tried caused any stinging or burning that might indicate a sensitivity to ingredients like glycerin or fragrances?
Want personalized information?
Type your question below to get evidence-based answers tailored to your situation.
References
- 1
Renal Disease in Primary Sjögren's Syndrome.
Aiyegbusi O, McGregor L, McGeoch L, et al.
Rheumatology and therapy 2021; (8(1)):63-80 doi:10.1007/s40744-020-00264-x.
PMID: 33367966 - 2
Sjögren's syndrome.
André F, Böckle BC
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2022; (20(7)):980-1002 doi:10.1111/ddg.14823.
PMID: 35775593 - 3
Management of sexual dysfunction in breast cancer survivors: a systematic review.
Seav SM, Dominick SA, Stepanyuk B, et al.
Women's midlife health 2015; (1()):9 doi:10.1186/s40695-015-0009-4.
PMID: 30766696 - 4
Clinical Practice Guidelines for Managing Genitourinary Symptoms Associated With Menopause.
Christmas M, Huguenin A, Iyer S
Clinical obstetrics and gynecology 2024; (67(1)):101-114 doi:10.1097/GRF.0000000000000833.
PMID: 38126460 - 5
Menopausal Hormone Therapy-Risks, Benefits and Emerging Options: A Narrative Review.
Arnautu AM, Nimigean VR, Nacea-Radu CA, et al.
International journal of molecular sciences 2025; (26(22)) doi:10.3390/ijms262211098.
PMID: 41303580 - 6
Practical Treatment Considerations in the Management of Genitourinary Syndrome of Menopause.
Kagan R, Kellogg-Spadt S, Parish SJ
Drugs & aging 2019; (36(10)):897-908 doi:10.1007/s40266-019-00700-w.
PMID: 31452067 - 7
Effect of a non-hormonal vaginal moisturizer on vaginal and vulvar health in postmenopausal women with breast cancer: A randomized clinical trial.
Martin BC, VItorino CN, Souza R, et al.
Maturitas 2026; (207()):108880 doi:10.1016/j.maturitas.2026.108880.
PMID: 41719902 - 8
Efficacy and safety of a non-hormonal intravaginal moisturizer for the treatment of vaginal dryness in postmenopausal women with sexual dysfunction.
Vale F, Rezende C, Raciclan A, et al.
European journal of obstetrics, gynecology, and reproductive biology 2019; (234()):92-95 doi:10.1016/j.ejogrb.2018.12.040.
PMID: 30677618 - 9
Management of genitourinary syndrome of menopause in female cancer patients: a focus on vaginal hormonal therapy.
Crean-Tate KK, Faubion SS, Pederson HJ, et al.
American journal of obstetrics and gynecology 2020; (222(2)):103-113 doi:10.1016/j.ajog.2019.08.043.
PMID: 31473229 - 10
Vaginal lubricants and moisturizers: a review into use, efficacy, and safety.
Potter N, Panay N
Climacteric : the journal of the International Menopause Society 2021; (24(1)):19-24 doi:10.1080/13697137.2020.1820478.
PMID: 32990054 - 11
Evaluation of sexual dysfunction among women with primary Sjögren's syndrome using a Female Sexual Function Index: a systematic review and meta-analysis.
D'Andrea S, Vinci A, Navarini L, et al.
The journal of sexual medicine 2025; (22(8)):1399-1408 doi:10.1093/jsxmed/qdaf110.
PMID: 40576390 - 12
Women harmed by vaginal laser for treatment of GSM-the latest casualties of fear and confusion surrounding hormone therapy.
Kaunitz AM, Pinkerton JV, Manson JE
Menopause (New York, N.Y.) 2019; (26(4)):338-340 doi:10.1097/GME.0000000000001313.
PMID: 30789455 - 13
What should guide our patient management of vulvovaginal atrophy?
Shapiro M
Climacteric : the journal of the International Menopause Society 2019; (22(1)):38-43 doi:10.1080/13697137.2018.1527306.
PMID: 30452294 - 14
Science of intracrinology in postmenopausal women.
Labrie F, Bélanger A, Pelletier G, et al.
Menopause (New York, N.Y.) 2017; (24(6)):702-712 doi:10.1097/GME.0000000000000808.
PMID: 28098598 - 15
Vaginal estrogen use for genitourinary symptoms in women with a history of uterine, cervical, or ovarian carcinoma.
Chambers LM, Herrmann A, Michener CM, et al.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2020; (30(4)):515-524 doi:10.1136/ijgc-2019-001034.
PMID: 32075898 - 16
Vaginal estrogen use and chronic disease risk in the Nurses' Health Study.
Bhupathiraju SN, Grodstein F, Stampfer MJ, et al.
Menopause (New York, N.Y.) 2018; (26(6)):603-610 doi:10.1097/GME.0000000000001284.
PMID: 30562320 - 17
Should I stay for local hormone therapy or should I go for radiofrequency to treat vulvovaginal atrophy? A patient preference trial.
Dell'Utri CM, Manzoni E, Bonfanti I, et al.
Menopause (New York, N.Y.) 2024; (31(9)):801-808 doi:10.1097/GME.0000000000002393.
PMID: 38954491
This page provides general educational information about managing vaginal dryness in Sjögren's syndrome. Always consult your gynecologist or rheumatologist to determine the safest and most effective treatment plan for your specific symptoms.
Stay up to date
Get notified when new research about Primary Sjögren's Syndrome is published.
No spam. Unsubscribe anytime.